- Home
- CHAR vs FBIOP Comparison
CHAR vs FBIOP Comparison
Compare CHAR & FBIOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHAR
- FBIOP
- Stock Information
- Founded
- CHAR 2024
- FBIOP N/A
- Country
- CHAR United States
- FBIOP United States
- Employees
- CHAR N/A
- FBIOP 101
- Industry
- CHAR
- FBIOP Biotechnology: Pharmaceutical Preparations
- Sector
- CHAR
- FBIOP Health Care
- Exchange
- CHAR NYSE
- FBIOP Nasdaq
- Market Cap
- CHAR N/A
- FBIOP N/A
- IPO Year
- CHAR 2024
- FBIOP N/A
- Fundamental
- Price
- CHAR $10.19
- FBIOP $6.35
- Analyst Decision
- CHAR
- FBIOP
- Analyst Count
- CHAR 0
- FBIOP 0
- Target Price
- CHAR N/A
- FBIOP N/A
- AVG Volume (30 Days)
- CHAR 15.6K
- FBIOP N/A
- Earning Date
- CHAR 01-01-0001
- FBIOP N/A
- Dividend Yield
- CHAR N/A
- FBIOP N/A
- EPS Growth
- CHAR N/A
- FBIOP N/A
- EPS
- CHAR N/A
- FBIOP N/A
- Revenue
- CHAR N/A
- FBIOP N/A
- Revenue This Year
- CHAR N/A
- FBIOP N/A
- Revenue Next Year
- CHAR N/A
- FBIOP N/A
- P/E Ratio
- CHAR $314.05
- FBIOP N/A
- Revenue Growth
- CHAR N/A
- FBIOP N/A
- 52 Week Low
- CHAR $9.88
- FBIOP N/A
- 52 Week High
- CHAR $10.71
- FBIOP N/A
- Technical
- Relative Strength Index (RSI)
- CHAR N/A
- FBIOP 52.45
- Support Level
- CHAR N/A
- FBIOP $6.36
- Resistance Level
- CHAR N/A
- FBIOP $6.80
- Average True Range (ATR)
- CHAR 0.00
- FBIOP 0.37
- MACD
- CHAR 0.00
- FBIOP -0.01
- Stochastic Oscillator
- CHAR 0.00
- FBIOP 55.97
About FBIOP Fortress Biotech Inc.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.